Siemens Healthineers introduces Innovance D-Dimer 2.0 assay

Siemens Healthineers has introduced its Innovance D-Dimer 2.0 assay globally following CE mark certification and 510(k) clearance from the US Food and Drug Administration. The assay facilitates in diagnosing and monitoring hypercoagulable disorders such as disseminated intravascular coagulation. The Innovance D-Dimer 2.0 assay forms part of the Siemens Healthineers thrombotic disorder range. Credit: Siemens Healthineers. Siemens Healthineers has introduced its Innovance D-Dimer 2.0 assay globally following CE mark certification and 510(k) clearance from the US Food and Drug Administration. The blood test assists clinicians in evaluating patients suspected of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis…

Source: Medical Device Network